Manchester Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19.5K | Sell |
|
|||||
|
2025
Q1 | $34K | Hold |
|
|||||
|
2024
Q4 | $39.4K | Hold |
|
|||||
|
2024
Q3 | $47K | Hold |
|
|||||
|
2024
Q2 | $54K | Hold |
|
|||||
|
2024
Q1 | $68.2K | Hold |
|
|||||
|
2023
Q4 | $62.6K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $61K | Hold |
|
|||||
|
2021
Q3 | $90K | Hold |
|
|||||
|
2021
Q2 | $130K | Hold |
|
|||||
|
2021
Q1 | $97K | Sell |
|
|||||
|
2020
Q4 | $141K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $8K | Buy |
|